Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Botulinum Toxin Predictable in the Management of Myofascial Pain Syndrome Related to Masticatory Muscles?

NCT06824324 is registered in ClinicalTrials.gov with Yassir R. Al-khannaq as lead sponsor.

NCT NCT06824324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06824324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Botulinum Toxin Predictable in the Management of Myofascial Pain Syndrome Related to Masticatory Muscles?
Lead sponsor
Yassir R. Al-khannaq
Phase
Phase 1/2
Overall status
Completed
Start date
March 12, 2024
Completion date
January 6, 2025
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofacial pain syndrome